Paeoniflorin Ameliorates Hyperprolactinemia-Induced Inhibition of Osteoblastogenesis by Suppressing the NF-κB Signaling Pathway

Hyperprolactinemia is a common endocrine disease in women of reproductive age. Research has shown that patients with hyperprolactinemia often have decreased bone mineral density and an increased risk of fractures. However, there is still a lack of effective treatments. Paeoniflorin, one of the prima...

Descripción completa

Detalles Bibliográficos
Autores principales: Sun, Xiaohong, Zhu, Keda, Feng, Chengcheng, Zhu, Jie, Chen, Shuangshuang, Tang, Wenkai, Wang, Zhifang, Xiao, Long, Li, Hong, Geng, Dechun, Wang, Zhirong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9033376/
https://www.ncbi.nlm.nih.gov/pubmed/35465073
http://dx.doi.org/10.1155/2022/4572033

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9033376/
https://www.ncbi.nlm.nih.gov/pubmed/35465073
http://dx.doi.org/10.1155/2022/4572033

Ejemplares similares